Testicular Cancer Information Center

Testicular Cancer News

Single Dose of Carboplatin as Effective as Radiation Therapy for Testicular Cancer (06/05/2008)
Among men with Stage I seminoma (a type of testicular cancer), post-surgery treatment with a single dose of the chemotherapy drug carboplatin is as effective as two to three weeks of radiation therapy, and also reduces the risk of cancer in the other testicle. These results were presented at the 2008 annual meeting of the American Society of Clinical Oncology (ASCO).

Recurrent Testicular Cancer Potentially Curable with High-dose Therapy and Stem Cell Transplant (07/26/2007)
According to an article recently published in the New England Journal of Medicine, metastatic testicular cancer that has recurred following standard therapy can potentially be cured with high-dose therapy and an autologous stem cell transplant.

Surgery Earlier In Life Reduces Risk of Testicular Cancer Among Males with Undescended Testis (05/04/2007)
According to an article recently published in the New England Journal of Medicine, surgery before the age of 13 for the treatment of undescended testis reduces the risk of testicular cancer compared with surgery later in life.

Survivors of Testicular Cancer at Increased Risk of Death from Other Causes (04/05/2007)
According to an article recently published in the Journal of the National Cancer Institute, men who have survived testicular cancer for at least one year are at a higher risk than the general population for death from all causes, particularly infection and circulatory and digestive diseases.

Firefighters Face Increased Risk of Cancer (11/15/2006)
According to the results of a study published in the Journal of Occupational and Environmental Medicine, firefighters have an increased risk of developing certain types of cancer.